Advertisement
Advertisement
U.S. Markets open in 2 hrs 49 mins
Advertisement
Advertisement
Advertisement
Advertisement

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
6.28+0.27 (+4.49%)
At close: 04:00PM EDT
6.39 +0.11 (+1.75%)
After hours: 07:59PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 8/16/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.66
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 329.59
52 Week Low 34.00
50-Day Moving Average 37.67
200-Day Moving Average 318.94

Share Statistics

Avg Vol (3 month) 37.58M
Avg Vol (10 day) 310.29M
Shares Outstanding 5359.33M
Implied Shares Outstanding 6N/A
Float 8299.67M
% Held by Insiders 12.99%
% Held by Institutions 173.39%
Shares Short (Jul 14, 2022) 416.33M
Short Ratio (Jul 14, 2022) 43.01
Short % of Float (Jul 14, 2022) 45.15%
Short % of Shares Outstanding (Jul 14, 2022) 44.52%
Shares Short (prior month Jun 14, 2022) 416.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 09, 2010
Last Split Factor 22:1
Last Split Date 3Oct 15, 2000

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin -4.89%
Operating Margin (ttm)19.72%

Management Effectiveness

Return on Assets (ttm)3.46%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)8.33B
Revenue Per Share (ttm)23.13
Quarterly Revenue Growth (yoy)-5.40%
Gross Profit (ttm)6.04B
EBITDA 3.14B
Net Income Avi to Common (ttm)-407M
Diluted EPS (ttm)-3.27
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.25B
Total Cash Per Share (mrq)3.45
Total Debt (mrq)23.17B
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.22
Book Value Per Share (mrq)-0.57

Cash Flow Statement

Operating Cash Flow (ttm)920M
Levered Free Cash Flow (ttm)1.55B
Advertisement
Advertisement